Treatment differences were -0.20 % ( 95 % CI -0.46 % to 0.06 % ) for exenatide versus insulin ( P = 0.185 ) , and -0.37 % ( 95 % CI -0.63 % to -0.12 % ) for exenatide versus pioglitazone ( P = 0.002 ) .